Safety profile of extended-release niacin in the AIM-HIGH trial

N Engl J Med. 2014 Jul 17;371(3):288-90. doi: 10.1056/NEJMc1311039.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis / drug therapy*
  • Delayed-Action Preparations
  • Drug Therapy, Combination
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Niacin / administration & dosage
  • Niacin / adverse effects*

Substances

  • Delayed-Action Preparations
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Niacin